Q3 2025 · 13F-HR
DCVC Opportunity Fund II GP, LLCholdings as filed
Filed 2025-11-14 · accession 0001104659-25-111912
$19.3M
Reported value
1
Positions
2025-09-30
Period end
The Brief · DCVC Opportunity Fund II GP, LLC · Q3 2025
AI · grounded in 13F
DCVC Opportunity Fund II GP, LLC closed its position in Rocket Lab Corp RKLB, selling $95.26M worth of shares. This was the fund's only move during the period. The fund ended the quarter with a total AUM of $19.28M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 75629V104 | RXRX | Recursion Pharmaceuticals, Inc. | $19.3M | 100.0% | 3,951,141 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.